BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$71.41 USD
+0.27 (0.38%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $71.42 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 0.79 |
EPS Last Quarter | 0.96 |
Last EPS Surprise | 68.42% |
ABR | 1.48 |
Earnings ESP
|
0.11% |
---|---|
Current Year | 3.24 |
Next Year | 4.05 |
EPS (TTM) | 2.62 |
P/E (F1) | 21.93 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 707.30M | 727.78M | 2.79B | 3.10B |
# of Estimates | 10 | 10 | 9 | 10 |
High Estimate | 727.08M | 753.30M | 2.83B | 3.29B |
Low Estimate | 689.00M | 664.00M | 2.71B | 2.90B |
Year ago Sales | 581.33M | 646.21M | 2.42B | 2.79B |
Year over Year Growth Est. | 21.67% | 12.62% | 15.52% | 11.09% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.79 | 0.81 | 3.24 | 4.05 |
# of Estimates | 12 | 10 | 13 | 12 |
Most Recent Consensus | 0.94 | 0.95 | 3.57 | 3.93 |
High Estimate | 0.94 | 0.95 | 3.57 | 4.93 |
Low Estimate | 0.71 | 0.74 | 3.14 | 3.30 |
Year ago EPS | 0.46 | 0.49 | 2.08 | 3.24 |
Year over Year Growth Est. | 71.74% | 65.31% | 55.77% | 24.83% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 5 | 4 | 4 | 4 |
Up Last 60 Days | 7 | 2 | 13 | 10 |
Down Last 7 Days | 1 | 1 | 1 | 2 |
Down Last 30 Days | 1 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 7 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.79 | 0.81 | 3.24 | 4.05 |
7 Days Ago | 0.79 | 0.82 | 3.26 | 4.11 |
30 Days Ago | 0.76 | 0.79 | 3.17 | 3.94 |
60 Days Ago | 0.74 | 0.83 | 2.78 | 3.65 |
90 Days Ago | 0.74 | 0.83 | 2.76 | 3.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.79 | 0.82 | 3.26 | 4.02 |
Zacks Consensus Estimate | 0.79 | 0.81 | 3.24 | 4.05 |
Earnings ESP | 0.11% | 1.08% | 0.55% | -0.83% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.96 | 0.71 | 0.49 | 0.46 | NA |
Estimate | 0.57 | 0.60 | 0.44 | 0.46 | NA |
Difference | 0.39 | 0.11 | 0.05 | 0.00 | 0.14 |
Surprise | 68.42% | 18.33% | 11.36% | 0.00% | 24.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more